Kabra Drugs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE323K01017
  • NSEID:
  • BSEID: 524322
INR
21.19
-0.05 (-0.24%)
BSENSE

Jun 10, 03:14 PM

BSE+NSE Vol: 56.62 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 271637,
    "name": "Kabra Drugs",
    "stock_name": "Kabra Drugs",
    "full_name": "Kabra Drugs Ltd",
    "name_url": "stocks-analysis/kabra-drugs",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "21.19",
    "chg": -0.05,
    "chgp": "-0.24%",
    "dir": -1,
    "prev_price": "21.24",
    "mcapval": "50.24 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524322,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE323K01017",
    "curr_date": "Jun 10, 03:14 PM",
    "curr_time": "15:16 PM",
    "last_traded_at": "Jun 10, 03:14 PM IST",
    "bse_nse_vol": "56.62 k",
    "exc_status": "Active",
    "traded_date": "Jun 10, 2026",
    "traded_date_str": "2026 06 10",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/kabra-drugs-271637-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Kabra Drugs Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kabra-drugs-ltd-is-rated-sell-by-marketsmojo-4035838",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/KabraDrugsLtd_mojoScore_4035838.png",
        "date": "2026-06-04 10:10:48",
        "description": "Kabra Drugs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "When is the next results date for Kabra Drugs Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-kabra-drugs-ltd-4007511",
        "imagepath": "",
        "date": "2026-05-22 23:21:30",
        "description": "The next results date for Kabra Drugs Ltd is scheduled for 29 May 2026...."
      }
    ],
    "total": 55,
    "sid": "271637",
    "stock_news_url": "https://www.marketsmojo.com/news/kabra-drugs-271637"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "03-Jun-2026",
      "details": "News paper Publication",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "30-May-2026",
      "details": "Press Release on Audited Financial Results for Quarter and Year ended 31 March 2026",
      "source": "BSE"
    },
    {
      "caption": "Undertaking For Non- Applicability Of Regulation 32 Of SEBI (LODR) Regulations 2015 For The Quarter Ended On 31St March 2026.",
      "datetime": "29-May-2026",
      "details": "Non-Applicability of Regulations 32 of SEBI (LODR)",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Newspaper Publication

03-Jun-2026 | Source : BSE

News paper Publication

Announcement under Regulation 30 (LODR)-Press Release / Media Release

30-May-2026 | Source : BSE

Press Release on Audited Financial Results for Quarter and Year ended 31 March 2026

Undertaking For Non- Applicability Of Regulation 32 Of SEBI (LODR) Regulations 2015 For The Quarter Ended On 31St March 2026.

29-May-2026 | Source : BSE

Non-Applicability of Regulations 32 of SEBI (LODR)

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available